SG CV19 VAER Portal

19/05/2021

Test your C0V1d Vaksin Knowledge
https://covidvaccinequiz.org/quiz/us/?fbclid=IwAR2zKz57Tet9lpMCsgQvyG176ZEUDtl3tnYkLM4kFGGRZ5Y38uzcF9XXldo

20/04/2021

There is a mandatory requirement for Singapore healthcare professionals to report serious adverse events. Can be found in the fact sheet for healthcare professionals. At this address.
https://www.hsa.gov.sg/therapeutic-products/register/special-access-routes/psar-emergency-therapeutic-product/emergency-tps-granted-psar-authorisation

Serious Adverse events to be reported irrespective of attribution to vaccination.

So are our healthcare professionals complying with these requirements? Who and how are these requirements enforced?

08/04/2021

Monitoring the safety profile of CO-VID-19 vaccines

HSA has issued a Dear Healthcare Professional Letter (DHCPL) to highlight to healthcare professionals the requirements on the safety monitoring of CO-VID-19 vac-cine(s) that has been authorised for use in Singapore. As the CO-VID-19 vac-cination programme is progressively rolled out, healthcare professionals are advised to remind vac-cine recipients to monitor any ad-verse events (AEs) that may occur with CO-VID-19 vac-cine(s) and to report all suspected serious adverse events (SAEs) to HSA:

all fatal and life-threatening events should be reported within 24 hours (Note: Fatal events are reportable as Coroner’s cases under the Coroners Act)

all other SAEs and Adverse Events of Special Interest (AESIs) are to be reported as soon as possible and within 48 hours
Healthcare professionals are also required to notify the National Immunisation Registry as soon as possible, within 48 hours, of all persons who have been vaccinated with the CO-VID-19 vac-cine(s) through the respective IT systems. HSA will continue to monitor the safety profile of CO-VID-19 vac-cine(s) and communicate any relevant updates to healthcare professionals.

Please refer to the letter for details.

Healthcare professional, Industry member, Therapeutic Products
Published: 29 Dec 2020
https://www.hsa.gov.sg/announcements/dear-healthcare-professional-letter/monitoring-the-safety-profile-of-covid-19-vaccines

HSA's Regulatory Information and Consumer Advisories
https://www.hsa.gov.sg/covid-19-information-and-advisories

HSA has issued a Dear Healthcare Professional Letter (DHCPL) to highlight to healthcare professionals the requirements on the safety monitoring of COVID-19 vaccine(s) that has been authorised for use in Singapore. As the COVID-19 vaccination programme is progressively rolled out, healthcare profe...

07/04/2021

In view of the few recent serious event cases circulating on social media which were not reported officially by the Authorities, we reached out to the affected individuals who came forward to share their experiences. There is a real concern that the public lack awareness that such events do occur and are not sure what to do if they encounter similar issues. We are inviting individuals from the public who had similar experiences to participate in this private survey to help raise awareness. We shall also offer affected individuals help and support where needed.

Your report will be strictly confidential unless you specifically give us permission to share your experiences. Only charts and numbers will be published weekly on Sunday to inform the public of the Events that occurred. No personal data shall be published.

A copy of your response and the weekly update will be sent to your email.

The survey is conducted by -
A group of concerned Singaporeans
Email: sgcv19aer@gmail.com

Disclaimer:
This survey is conducted in good faith and on a goodwill basis by volunteers. Any help, assistance or support offered are not guaranteed.
Participants to the survey shall also be based on a voluntary basis and in good faith.

Note:
The local public are welcomed to post their stories of similar experiences in the visitor post section.